Private equity firms GHO Capital Partners LLP and The Vistria Group have acquired pharmaceutical contract development and manufacturing organization Alcami Corporation.
GHO Capital and The Vistria Group will acquire a 50/50 controlling interest in Alcami from funds affiliated with Madison Dearborn Partners and Ampersand Capital Partners. Terms of the transaction were not disclosed.
Alcami Corporation is headquartered in Durham, North Carolina, with more than 40 years of experience advancing products through every development life-cycle stage. Leveraging 675,000 square feet across the U.S., Alcami serves pharmaceutical and biotech companies of all sizes.
Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. Since October 2015, GHO Capital has invested €3.9 billion in 19 platform companies across three flagship funds. The Vistria Group is a private investment firm focused on investing in middle-market companies in the healthcare, education and financial services sectors. It was founded in 2013. The Vistria Group has raised more than $5.1 billion across six funds.
According to the LevinPro HC database, this was the 30th contract development manufacturing organization transaction of 2022. This compares with 31 contract development manufacturing organization deals recorded between January 1, 2021 and November 9, 2021.
